 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
414.977.4254
bethfj@merge.com
|
|
MERGE HEALTHCARE TO UNVEIL NEWEST IMAGING WORKFLOW SOLUTIONS
AT VIENNA, AUSTRIA RADIOLOGICAL CONFERENCE
Milwaukee, WI, Feb. 22, 2007 – Merge Healthcare (NASDAQ: MRGE; TSX: MRG), a leading medical imaging software and services provider, today announced that it will unveil its newest software solutions at the European College of Radiology Annual Conference, held in Vienna, Austria, March 9-12, 2007. Merge Healthcare will exhibit in Booth #23 (Extension Expo A), showcasing RIS, PACS, EPR Mammography, PET/CT, Orthopaedic and connectivity software solutions that are relevant to increasing clinical productivity for hospitals, imaging centers and clinics.
“Merge Healthcare’s solutions are extremely flexible and can be optimally adapted to an existing, heterogeneous IT infrastructure,” said Jacques Cornet, President, Merge Healthcare-EMEA. "In today’s radiology environment, continuous and flexible solutions are crucial for ensuring quality care while enhancing patient safety. Merge Healthcare delivers integrated end-to-end software solutions and professional services that are transforming the way our customers interact with referring physicians, manage their workflow, position their businesses in their markets and deliver imaging and information services to their customers".
The software allows the integration of pre-medical, clinical, rehabilitation and follow-up treatment. System interfaces and equipment to form clinic or practical networks are also available. Additionally, both technology and software have been developed for a comprehensive range of medical specialties including radiology, women’s health, oncology and orthopaedics.
Thousands of hospitals, imaging centers and specialty clinics throughout the world use solutions from Merge Healthcare, the makers of eFilm Workstation™, MergeBox™ connectivity solutions , and Fusion RIS/PACS™ solutions. Merge Healthcare is a leading technological company in the field of innovative solutions for Radiology. Many of Merge Healthcare’s customers have played an important role in guiding the company with its newest offerings, including:
Fusion PACS GL™
Merge Healthcare will showcase its industry-leading 64-bit capabilities in Fusion PACS GL, which enables the easy and simultaneous loading of thousands of images, allowing radiologists to quickly read very large studies with multiple relevant prior studies, regardless of size. Other new capabilities to be unveiled for its Fusion PACS GL system will include: leading edge communication tools such as instant messaging and multiple interrupt sessions, efficient reading tools like key images and hanging protocols, and advanced reading tools such as triangulate and slab MPR.
Fusion RIS GL™
Merge Healthcare will also highlight its Fusion RIS GL solution, which has become the cornerstone of many imaging businesses, as it provides a workflow solution that accelerates productivity from scheduling through billing. The Fusion RIS GL optimizes each radiology workflow through numerous configuration options and the seamless integration of add-on modules as needed. Because the architecture is Microsoft Windows® based and the solution is run with a standard user interface, Fusion RIS GL is easy to learn and run by all members of the imaging team.
Clinical Applications
Several specialty clinical applications will be demonstrated, including:
Merge Mammo™ – A multi-modality, vendor-neutral digital mammography workstation, Merge Mammo allows organizations to display images simultaneously from different mammography systems and to read all breast imaging studies from a single station, including images from the newly FDA-approved CR for mammography. Merge Mammo’s newest features showing at ECR include: enhanced full-resolution viewing, algorithm-driven display capabilities to optimize screen real estate, and improved inverted imaging.
Merge PET/CT™ – a vendor-neutral software application designed to optimize digital reading for PET/CT studies using advanced imaging capabilities combined with fast and efficient workflow for PET/CT reporting.
Merge Ortho™ - combining image manipulation and automation within an architecture designed for integration and customization, Merge Ortho™ offers a comprehensive digital solution for joint arthroplasty, trauma, deformity correction and more. Merge Ortho™ supports surgical planning, templating, archiving and distribution.
Those interested in scheduling a demo at ECR can visit www.merge.com/EMEA/ecr
# # #
Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.merge.com.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
